Next Article in Journal
Finite-Element Modeling of Viscoelastic Cells During High-Frequency Cyclic Strain
Previous Article in Journal
Experimental Models for Investigating Intra-Stromal Migration of Corneal Keratocytes, Fibroblasts and Myofibroblasts
J. Funct. Biomater. 2012, 3(1), 199-208; doi:10.3390/jfb3010199
Article

Sustained Delivery of Chondroitinase ABC from Hydrogel System

1,2,†,* , 2,†
,
1,2,†
,
2
,
2
,
2
,
2
,
1
 and
1,2
1 Department of Chemistry, Materials and Chemical Engineering “Giulio Natta”, Politecnico di Milano, via Mancinelli 7, Milan 20131, Italy 2 Department of Neuroscience, Mario Negri Institute for Pharmacological Research, via La Masa 19, Milan 20156, Italy These authors contributed equally to this work.
* Author to whom correspondence should be addressed.
Received: 19 December 2011 / Revised: 27 February 2012 / Accepted: 13 March 2012 / Published: 19 March 2012
(This article belongs to the Special Issue Advances in Injectable Biomaterials)
View Full-Text   |   Download PDF [567 KB, uploaded 20 March 2012]   |   Browse Figures

Abstract

In the injured spinal cord, chondroitin sulfate proteoglycans (CSPGs) are the principal responsible of axon growth inhibition and they contribute to regenerative failure, promoting glial scar formation. Chondroitinase ABC (chABC) is known for being able to digest proteoglycans, thus degrading glial scar and favoring axonal regrowth. However, its classic administration is invasive, infection-prone and clinically problematic. An agarose-carbomer (AC1) hydrogel, already used in SCI repair strategies, was here investigated as a delivery system capable of an effective chABC administration: the material ability to include chABC within its pores and the possibility to be injected into the target tissue were firstly proved. Subsequently, release kinetic and the maintenance of enzymatic activity were positively assessed: AC1 hydrogel was thus confirmed to be a feasible tool for chABC delivery and a promising device for spinal cord injury topic repair strategies.
Keywords: chondroitinase ABC; hydrogels; drug delivery; spinal cord injury chondroitinase ABC; hydrogels; drug delivery; spinal cord injury
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Share & Cite This Article

Further Mendeley | CiteULike
Export to BibTeX |
EndNote
MDPI and ACS Style

Rossi, F.; Veglianese, P.; Santoro, M.; Papa, S.; Rogora, C.; Dell’Oro, V.; Forloni, G.; Masi, M.; Perale, G. Sustained Delivery of Chondroitinase ABC from Hydrogel System. J. Funct. Biomater. 2012, 3, 199-208.

View more citation formats

Related Articles

Article Metrics

Comments

Cited By

[Return to top]
J. Funct. Biomater. EISSN 2079-4983 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert